Result of search

Impact factor = 1.483

  1. Julianna Pisch, Tibor Moskovitz, Olga Ésik, Peter Homel, Steven Keller: Concurrent Paclitaxel-Cisplatin and Twice-a-DayIrradiation in Stage IIIA and IIIB NSCLC Shows Improvement in Local Control and Survival with Acceptable Hematologic Toxicity. Pathology & Oncology Research, Vol 8, Nr 3, 163-169, 2002.
     
ad